X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (47) 47
oncology (40) 40
female (34) 34
male (34) 34
middle aged (31) 31
aged (27) 27
adult (21) 21
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
fluorouracil - administration & dosage (16) 16
index medicus (16) 16
cancer (15) 15
chemotherapy (14) 14
aged, 80 and over (12) 12
treatment outcome (12) 12
carcinoma (10) 10
combined modality therapy (10) 10
adenocarcinoma (9) 9
drug administration schedule (9) 9
leucovorin - administration & dosage (9) 9
5-fluorouracil (8) 8
adenocarcinoma - therapy (8) 8
fluorouracil (8) 8
survival analysis (8) 8
adenocarcinoma - mortality (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
care and treatment (7) 7
cisplatin - administration & dosage (7) 7
colorectal neoplasms - drug therapy (7) 7
leucovorin (7) 7
neoplasm staging (7) 7
pharmacology & pharmacy (7) 7
radiotherapy (7) 7
therapy (7) 7
adenocarcinoma - drug therapy (6) 6
cisplatin (6) 6
esophageal neoplasms - mortality (6) 6
esophageal neoplasms - therapy (6) 6
fluorouracil - therapeutic use (6) 6
infusions, intravenous (6) 6
preoperative chemotherapy (6) 6
surgery (6) 6
thymidylate synthase - genetics (6) 6
trial (6) 6
carcinoma, squamous cell - therapy (5) 5
chemotherapy, adjuvant (5) 5
colorectal cancer (5) 5
esophageal cancer (5) 5
esophageal neoplasms - drug therapy (5) 5
neoadjuvant therapy (5) 5
organoplatinum compounds - administration & dosage (5) 5
pancreatic cancer (5) 5
phase-ii (5) 5
polymerase chain-reaction (5) 5
radiation therapy (5) 5
radiation-therapy (5) 5
stomach cancer (5) 5
stomach neoplasms - drug therapy (5) 5
survival (5) 5
adenocarcinoma - pathology (4) 4
adjuvant chemotherapy (4) 4
analysis (4) 4
carcinoma, squamous cell - drug therapy (4) 4
carcinoma, squamous cell - mortality (4) 4
colorectal neoplasms - pathology (4) 4
combination (4) 4
disease-free survival (4) 4
esophageal neoplasms - pathology (4) 4
esophagus (4) 4
mutations (4) 4
neoplasms - drug therapy (4) 4
oxaliplatin (4) 4
patients (4) 4
polymerase chain reaction (4) 4
radiotherapy dosage (4) 4
retrospective studies (4) 4
squamous-cell carcinoma (4) 4
adenocarcinoma - surgery (3) 3
administration, oral (3) 3
antimetabolites, antineoplastic - administration & dosage (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - therapeutic use (3) 3
base sequence (3) 3
cancer research (3) 3
carcinoma, squamous cell - radiotherapy (3) 3
chemoradiation (3) 3
chemoradiotherapy (3) 3
chi-square statistics (3) 3
colon-cancer (3) 3
colorectal neoplasms - enzymology (3) 3
colorectal neoplasms - genetics (3) 3
colorectal-cancer (3) 3
drug evaluation (3) 3
esophageal neoplasms - genetics (3) 3
esophageal neoplasms - radiotherapy (3) 3
evaluation (3) 3
floxuridine - administration & dosage (3) 3
folinic acid (3) 3
follow-up studies (3) 3
gastrectomy (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1990, Volume 14, no. 3., 119-159.
Book
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e18060 - e18060
Journal Article
Cancer, ISSN 0008-543X, 04/2018, Volume 124, Issue 8, pp. 1791 - 1797
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e16031 - e16031
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 5282 - 5282
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. TPS3627 - TPS3627
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2015, Volume 33, Issue 3_suppl, pp. 324 - 324
324 Background: Pancreatic cancer is well known for its aggressive clinical course and resistance to chemotherapy. The advent of new mouse models of pancreatic... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e13517 - e13517
Journal Article
The Oncologist, ISSN 1083-7159, 01/2020, Volume 25, Issue 1, pp. e53 - e59
Background A standard approach to treating resectable esophageal adenocarcinoma is chemoradiotherapy (CRT) followed by surgery; however, recurrence is common.... 
Cetuximab | Chemoradiotherapy | Esophageal adenocarcinoma | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4_suppl, pp. TPS199 - TPS199
TPS199 Background: ESCC comprises 80% of esophageal cancers worldwide. Preoperative chemoRT is a standard-of-care based on the CROSS trial ( N Engl J Med... 
Journal Article
Cancer Causes & Control, ISSN 0957-5243, 2/2018, Volume 29, Issue 2, pp. 253 - 260
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2016, Volume 34, Issue 4_suppl, pp. 271 - 271
271 Background: Pancreatic cancer is well known for its aggressive clinical course and resistance to chemotherapy. A Phase I trial of CD40 immunotherapy in... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4_suppl, pp. 121 - 121
121 Background: E2205 was a single-arm, phase II trial that added an epidermal growth factor receptor (EGF-R) inhibitor, cetuximab (C), to CRT. The trial was... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2016, Volume 34, Issue 26_suppl, pp. 155 - 155
155 Background: Malnutrition incidence in cancer approaches 85%, disproportionately burdening those with lung, GI, and advanced stage cancers. Malnourished... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2016, Volume 34, Issue 4_suppl, pp. 614 - 614
614 Background: NACR followed by total mesorectal excision (TME) is standard of care for LARC. However, only 10-20% of patients achieve complete pathologic... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.